Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-11
DOI
10.1038/srep19137
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress
- (2015) Zeng Si Wang et al. BMC Nephrology
- Astragalosides from Radix Astragali benefits experimental autoimmune encephalomyelitis in C57BL /6 mice at multiple levels
- (2014) Yi-Xin He et al. BMC Complementary and Alternative Medicine
- Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats
- (2014) Jianguo Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Potential chemoprevention of LPS-stimulated nitric oxide and prostaglandin E2 production by α-l-rhamnopyranosyl-(1→6)-β-d-glucopyranosyl-3-indolecarbonate in BV2 microglial cells through suppression of the ROS/PI3K/Akt/NF-κB pathway
- (2014) Matharage Gayani Dilshara et al. NEUROCHEMISTRY INTERNATIONAL
- Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF-κB-mediated inflammatory genes expression
- (2013) Dingkun Gui et al. CYTOKINE
- Anti-inflammatory effects of β-hydroxyisovalerylshikonin in BV2 microglia are mediated through suppression of the PI3K/Akt/NF-kB pathway and activation of the Nrf2/HO-1 pathway
- (2013) Rajapaksha Gedara Prasad Tharanga Jayasooriya et al. FOOD AND CHEMICAL TOXICOLOGY
- Pharmacokinetics and tolerance of toal astragalosides after intravenous infusion of astragalosides injection in healthy Chinese volunteers
- (2013) Meijuan Xu et al. PHYTOMEDICINE
- Astragaloside IV Attenuates Experimental Autoimmune Encephalomyelitis of Mice by Counteracting Oxidative Stress at Multiple Levels
- (2013) Yixin He et al. PLoS One
- The PI3K/Akt pathway is required for LPS activation of microglial cells
- (2012) Concetta Saponaro et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis
- (2012) Azhar R. Hussain et al. PLoS One
- Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation
- (2011) Wei Bi et al. BRAIN RESEARCH
- Mechanisms of Glucocorticoids in the Control of Neuroinflammation
- (2011) N. Schweingruber et al. JOURNAL OF NEUROENDOCRINOLOGY
- Neuroinflammation: Modulation by flavonoids and mechanisms of action
- (2011) Jeremy P.E. Spencer et al. MOLECULAR ASPECTS OF MEDICINE
- Dexamethasone prevents LPS-induced microglial activation and astroglial impairment in an experimental bacterial meningitis co-culture model
- (2010) Daniel Hinkerohe et al. BRAIN RESEARCH
- Mechanisms Underlying Inflammation in Neurodegeneration
- (2010) Christopher K. Glass et al. CELL
- Cerebral interleukin-15 shows upregulation and beneficial effects in experimental autoimmune encephalomyelitis
- (2010) Xiaojun Wu et al. JOURNAL OF NEUROIMMUNOLOGY
- Anti-hepatitis B Virus Activities of Astragaloside IV Isolated from Radix Astragali
- (2009) Shuguang Wang et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Protopanaxadiol and protopanaxatriol bind to glucocorticoid and oestrogen receptors in endothelial cells
- (2009) Kar Wah Leung et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Astragaloside IV attenuates lipolysis and improves insulin resistance induced by TNFαin 3T3-L1 adipocytes
- (2008) Boren Jiang et al. PHYTOTHERAPY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now